| Record ID | marc_columbia/Columbia-extract-20221130-002.mrc:472969298:1183 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-002.mrc:472969298:1183?format=raw |
LEADER: 01183cam a2200289 a 4500
001 872851
005 20220526030425.0
008 900108t19901990nyua 000 0 eng d
035 $a(OCoLC)507984068
035 $a(OCoLC)ocn507984068
035 $a(CStRLIN)NYCG90-B1072
035 $9AES6809CU
035 $a(NNC)872851
035 $a872851
040 $aNhD$cNhD$dNNC
043 $an-us---
090 $aHD9999.B443$bU54 1990g
245 00 $aBiotech 90: into the next decade :$bfourth annual survey of business and financial issues in America's most promising industry /$cG. Steven Burrill with the Ernst & Young High Technology Group.
260 $aNew York, N.Y. :$bMary Ann Liebert,$c[1990], ©1990.
300 $a247 pages :$billustrations ;$c27 cm
336 $atext$2rdacontent
337 $aunmediated$2rdamedia
338 $avolume$2rdacarrier
650 0 $aBiotechnology industries$zUnited States.$0http://id.loc.gov/authorities/subjects/sh2007102018
700 1 $aBurrill, G. Steven.$0http://id.loc.gov/authorities/names/n88035373
710 2 $aErnst & Young.$bHigh Technology Group.$0http://id.loc.gov/authorities/names/n90717657
852 00 $boff,bus$hHD9999.B443$iU54 1990g